Oxford Nanopore Technologies plc

WHO'M
ai
Digital Profiler. Simply click the AI button
CUSIP

G6840E103
SEDOL

BP6S8Z3
CIK

N/A

nanoporetech.com
LEI:
FIGI: BBG012SQ4DZ5
ONT

Oxford Nanopore Technologies plc
GICS: 35203010 · Sector: DNA sequencing · Sub-Sector: -
AI
PROFILER
NAME
Oxford Nanopore Technologies plc
ISIN
GB00BP6S8Z30
TICKER
ONT
MIC
XLON
REUTERS
ONT.L
BLOOMBERG
ONT LN
EN 728x90
FOR INVESTORS
FOR TRADERS
Securities Trading Warrants
In this section you will find transaction histories for short sales.
ai
NALIZER
Short sellers are obliged to report when building up positions from 0.50% and when reducing positions up to 0.50%. If there are open positions >= 0.50% in the reporting registers, these are shown in the following overview.
Five Short sale positions >= 0.50% are currently registered as reportable-relevant
Date Position Holder Position # Action
20.12.2024 Qube Research & Technologies Limited 0,62% 1
20.12.2024 Systematica Investments Limited 0,51% 3
20.12.2024 Millennium International Management LP 1,00% 10
28.11.2024 ExodusPoint Capital Management, LP 0,50% 1
11.01.2024 JPMorgan Asset Management (UK) Ltd 0,51% 1
The overview shows all positions and their last reported status. Please note that when reducing positions, falling below the 0.50% limit means that the mandatory reporting obligations no longer have to be applied. As a rule, it can be assumed that the positions have been completely reduced following a longer period of inactivity. Positions < 0.50% are therefore only of limited significance.
Date Position Holder Position # Action
20.12.2024 Qube Research & Technologies Limited 0,62% 1
20.12.2024 Systematica Investments Limited 0,51% 3
20.12.2024 Millennium International Management LP 1,00% 10
28.11.2024 ExodusPoint Capital Management, LP 0,50% 1
11.01.2024 JPMorgan Asset Management (UK) Ltd 0,51% 1
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Information on product placements
The information provided in this area is compiled with care and prepared and processed in complex technical process steps. Quality assurance is an integral part of the methods and procedures used. A plausibility check is carried out to the extent that the source data allows. Before further use, especially in the course of any investment decisions, we recommend consulting at least one second independent source for validation.

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S